Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

2articles mentioning treatments

2treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: antifibrotics ×

antifibrotics

This treatment is selected. Its supporting articles are shown below.

antifibrotics2

Articles mentioning antifibrotics

2 articles · page 1 of 1

Baseline characteristics from the EXCITING-ILD registry

bmjresp · abstract · 2025-12-25 · 1 matching annotations

91.8%

antifibrotics sarcoidosis pneumoconiosis idiopathic pulmonary fibrosis Pulmonary hypertension connective tissue disease-associated ILD Interstitial lung diseases EXCITING-ILD registry IPF

…a notable increase. In IPF, the number of patients treated with antifibrotics increased from 35.2% before 2015 to 48.4% in 2019.Conclusion Th…

Differences in disease characteristics and outcomes as determined by biological sex in a large UK idiopathic pulmonary fibrosis population: analysis from the British Thoracic Society, Interstitial Lung Disease registry data

bmjresp · abstract · 2025-09-25 · 1 matching annotations

75.7%

antifibrotics gastro-oesophageal reflux disease cardiovascular disease Diabetes major depressive illness nintedanib pirfenidone idiopathic pulmonary fibrosis lung cancer

… high resolution CT radiological pattern, eligibility/uptake of antifibrotics and survival.Results Of 7177 cases, 77.8% (n=5587) were male, m…